Reverse Transcriptase Inhibitors in HIV/AIDS Therapy

Despite significant pharmacological advances, the backbone of the most highly active antiretroviral therapy regimens for controlling HIV/AIDS is still a combination of reverse transcriptase inhibitors (RTIs) first discovered in the late 1980s. In Reverse Transcriptase Inhibitors in HIV/AIDS Therapy,...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Skowron, Gail (Editor ), Ogden, Richard (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Totowa, NJ : Humana Press : Imprint: Humana, 2006.
Edición:1st ed. 2006.
Colección:Infectious Disease
Temas:
Diseases.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Structural Studies on HIV Reverse Transcriptase Related to Drug Discovery
  • Zidovudine, Lamivudine, and Abacavir
  • Stavudine, Didanosine, and Zalcitabine
  • Emtricitabine
  • Nucleotide Analogs
  • Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
  • Pharmacokinetics of Reverse Transcriptase Inhibitors
  • Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy
  • Mitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy
  • Mitochondrial Toxicity and Lipodystrophy
  • Nevirapine
  • Efavirenz
  • Delavirdine
  • Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors
  • Vertical Transmission of HIV and Therapeutic Interventions
  • New Reverse Transcriptase Inhibitors in Development
  • Antiretroviral Drugs for Millions.

Ejemplares similares